Trending archive
Every article that has appeared in Trending stays here. Search by title, journal, author or PMID, and narrow by date.
1821 articles
September 202624
Bone metastases in lung carcinoids: current challenges in diagnosis and treatment -A systematic review of an unexplored issue.
This systematic review examined bone metastases (BMs) in lung carcinoid patients, revealing an incidence of 17.2%. The study highlighted the challenges in diagnosis and treatment, noting that BMs were predominantly…
Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature.
Two patients with metastatic renal cell carcinoma developed bullous pemphigoid after treatment with immune-checkpoint inhibitors.
Cost-effectiveness analysis of a virtually administered pain coping skills training intervention in women with breast cancer in underserved areas.
This randomized controlled trial evaluated the cost-effectiveness of a virtual pain coping skills training (mPCST) intervention for women with breast cancer in underserved areas.
Robotic left lower lobectomy for Stage IB adenocarcinoma with critical exercise capacity.
This video tutorial demonstrates a robotic-assisted left lower lobectomy in a 71-year-old female with critical exercise capacity. Preoperative evaluation revealed a 32 mm cavitated tumour in the left lower lobe.
Multidisciplinary Collaborative Treatment of Mediastinal Castleman Disease: A Case Report.
A 28-year-old man presented with cough and hemoptysis, leading to the discovery of a mediastinal mass via chest CT. A bronchoscopy-guided biopsy indicated lymphoid tissue hyperplasia.
Recurrent C19MC-altered embryonal tumors with multilayered rosettes: outcomes of stereotactic radiosurgery.
This report discusses three pediatric patients with recurrent embryonal tumors with multilayered rosettes (ETMR) who were treated with stereotactic radiosurgery (SRS) after initial gross total resection and adjuvant…
A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART).
The JCOG2314 trial is a multicenter, randomized phase II/III study evaluating tirabrutinib as a salvage treatment for refractory primary central nervous system lymphoma (PCNSL) compared to whole-brain radiotherapy…
Remarkable efficacy of ivonescimab-based second-line therapy in advanced lung adenocarcinoma resistant to chemoimmunotherapy: a case report.
A 41-year-old male with stage IVA lung adenocarcinoma, initially treated with camrelizumab, pemetrexed, and carboplatin, experienced disease progression after achieving a partial response.
Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
The MATTERHORN trial, a global, randomised, double-blind, placebo-controlled phase 3 study, evaluated the effect of perioperative durvalumab plus FLOT in 948 adults with resectable gastric and gastro-oesophageal…
Comparative Efficacy and Safety of Transarterial Therapies for Unresectable Neuroendocrine Liver Metastases: A Systematic Review.
This systematic review compared transarterial embolisation, conventional and drug-eluting-bead chemoembolisation, and radioembolisation for adults with unresectable neuroendocrine liver metastases.
Utility of 99m Tc-FAPI-46 SPECT/CT in Restaging Hepatocellular Carcinoma : A Case Report.
A 54-year-old man with hepatocellular carcinoma developed diffuse bone pain six months after radiofrequency ablation. Restaging with 99mTc-FAPI-46 SPECT/CT showed locally active primary HCC and widespread FAPI-avid bone…
Pomalidomide plus bortezomib and dexamethasone for newly diagnosed multiple myeloma with renal impairment: Randomized phase II study (POM-MM-003).
This open-label, multicenter, randomized phase II study compared pomalidomide, bortezomib, and dexamethasone (PVd) with bortezomib and dexamethasone (Vd) in 82 patients with newly diagnosed symptomatic multiple myeloma…
Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial.
This analysis of the SU2C-SARC032 phase II randomised trial evaluated personalized circulating tumour DNA (ctDNA) profiling in 106 patients with high-risk, localized soft tissue sarcoma treated with preoperative…
Biopsychosocial Antecedents and Symptom Burden Among Children Undergoing Cancer Treatment: A Systematic Review.
This systematic review synthesized evidence on factors associated with symptom burden in children under 18 undergoing cancer treatment. Following screening of 5,254 articles, 74 were included.
New Observations on a Low-Grade Diffusely Infiltrative Tumour, SMARCB1 Mutant, Arguing for a New Tumour Type.
This report details two cases of low-grade diffusely infiltrative tumour (LGDIT) in an 18-year-old and a 50-year-old male, both presenting with supratentorial lesions.
Extraskeletal Ewing Sarcoma Involving the Abdominal Cavity and Retroperitoneum on 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT.
Primary extraosseous Ewing sarcoma located in the abdominal cavity and retroperitoneum is rare. We report the 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT imaging findings of intra-abdominal Ewing sarcoma.
Combined 177Lu-FAP-2286 Therapy and Chemotherapy in Extraskeletal Ewing Sarcoma With Multiple Metastases.
A 23-year-old male with metastatic extraskeletal Ewing sarcoma, who could not tolerate standard chemotherapy, was treated with 177Lu-FAP-2286 followed by reduced-dose chemotherapy.
Impact of PerioperAtive LidocAine Infusions on Enhanced Recovery After Noncardiac Surgery (IMPALA-ERAS) in an inpatient setting: rationale, design and protocol for a sequential, repeated crossover trial.
The IMPALA-ERAS trial is a single-centre, pragmatic, cluster-randomised, double-blinded, placebo-controlled study evaluating the effects of perioperative intravenous lidocaine infusions on postoperative recovery in 2290…
Camrelizumab plus nimotuzumab as second-line therapy for advanced esophageal squamous cell carcinoma: a multicenter phase II study.
This multicenter phase II study evaluated the efficacy and safety of camrelizumab plus nimotuzumab in 46 patients with advanced esophageal squamous cell carcinoma (ESCC) after first-line therapy failure.
Total en bloc resection of a giant cell tumour of the cervical spine involving the vertebral artery.
A woman in her 20s presented with neck pain and was diagnosed with a giant cell tumour of the cervical spine that encased the left vertebral artery.
Diffuse skeletal and bone marrow metastases mimicking plasma cell dyscrasia in advanced lung adenocarcinoma.
A man in his late 40s presented with chest pain, cough, and dyspnoea. Imaging showed left lung collapse and pleural involvement, confirmed as pulmonary adenocarcinoma via thoracoscopic biopsy.
Compliance With Ecological Momentary Assessment Among Patients With Cancer: Systematic Review and Meta-Analysis.
This systematic review and meta-analysis evaluated compliance with ecological momentary assessment (EMA) among 13,565 cancer patients.
Multidisciplinary mHealth Rehabilitation for Patients With Abdominal Cancer Who Are Receiving Chemoradiotherapy: Randomized Phase II Trial.
This randomized phase II trial evaluated a multidisciplinary mHealth rehabilitation program for 111 patients with abdominal cancer undergoing concurrent chemoradiotherapy (CCRT).
Suspected Donor-Site Implantation of Floor of Mouth Squamous Cell Carcinoma After Free Flap Reconstruction: A Case Report.
A 57-year-old man presented with a mass in the left floor of the mouth, diagnosed as squamous cell carcinoma (SCC). Following resection and reconstruction with a free flap, a mass developed in the left thigh scar five…
Stay updated for free
Get the 3 most interesting publications in one specialty each week.
Weekly email. Unsubscribe anytime.
Want this personalized?
Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.
- Your specialties
- Your filters and thresholds
- Clinical Research + Case Reports, tuned separately
- Automatic weekly delivery
- Audio and text
Prefer listening? Personalized audio digests are available with Pro.